Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Urologic Diseases × Tranexamic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Diseases 1 Urinary Retention 1 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Patient Satisfaction 1 Hemorrhage 1 Hematuria 1

Interventions

vofatamab 2 B701 protein, Human herpesvirus 6 2 pembrolizumab 1 Tranexamic Acid 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04555343 2021-11-05

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

Fraser Health

Phase 1/2 Completed

Urinary Bladder Neoplasms, Hematuria, Prostatic Neoplasms, Urologic Diseases, Urinary Retention, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡